The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 475.50
Bid: 473.00
Ask: 478.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.057%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 475.50
OCI Live PriceLast checked at -
Oakley Capital Investments is an Investment Trust

To achieve capital appreciation through investments in a diversified portfolio of private mid-market businesses primarily in Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Results 2023

14 Mar 2024 07:00

RNS Number : 7783G
Oakley Capital Investments Limited
14 March 2024
 

14 March 2024

Oakley Capital Investments Limited

Final results for the Year Ended 31 December 2023

Oakley Capital Investments Limited1 ("OCI" or the "Company") today announces its final results for the year ended 31 December 2023. OCI is a listed investment company providing consistent, long-term returns in excess of the FTSE All-Share Index by investing in funds managed by Oakley Capital2 ("Oakley").

The Oakley Funds3 invest primarily in unquoted, profitable, pan-European businesses with recurring revenues, and across four focus sectors. Oakley's origination capabilities with proven value creation drivers help management teams accelerate growth and produce consistently superior returns for investors.  

Strong growth and investment activity in a period of macroeconomic uncertainty

 

Highlights for the year ended 31 December 2023

?

Net Asset Value ("NAV") per share of 684 pence and NAV of £1,207 million

?

Total NAV return per share, including dividends, of 4% (+27 pence), or c.6% before the impact of foreign exchange

?

Total shareholder return of 18%

?

Investments of £175 million and share of proceeds of £266 million

?

Outstanding commitments of £1,015 million

?

Year-end cash and available credit facilities of £382 million

?

Final dividend of 2.25 pence, taking dividends declared to 4.5 pence

 

Portfolio highlights

?

Average portfolio company year-on-year EBITDA growth of 14% (2022: 22%)

?

Average portfolio company valuation multiple (EV/EBITDA) of 16.4x (2022: 15.9x)

?

Portfolio value increase was driven 65% by EBITDA growth, and 35% by multiple expansion

?

Average net debt/EBITDA ratio of 4.2x (2022: 4.3x)

?

The key drivers of NAV growth were:

?

IU Group (+10 pence): enrolments grew 30%+ to 140,000+ students

?

North Sails (+9 pence): revenue and profits hit record and ahead of target

?

Idealista (+7 pence): strong results across core markets in Southern Europe

?

Foreign exchange: (-12 pence): 2+% change in EUR:GBP

 

Portfolio overview

 

OCI's portfolio of private equity investments delivered robust trading during the period:

?

Earnings - an average 14% organic EBITDA growth demonstrates the portfolio's ability to sustain performance through economic cycles

?

Valuations - the average valuation multiple modestly increased to 16.4x, partially reflecting strength in peer multiples. The 4% increase in total NAV reflects a cautious approach to trading outlook and portfolio company valuation multiples

?

Leverage - average net debt/EBITDA declined to 4.2x which compares to a private equity industry average of between 6 to 7x

 

Read more about the Portfolio's performance in the Annual Report here.

 

Proceeds

 

OCI's look-through share of proceeds from exits and refinancings during the year totalled £266 million, consisting of:

?

Realisations - £240 million - IU Group at gross return of 85% IRR

?

Refinancings - £26 million - idealista and Cegid completed debt refinancings

 

Investments

OCI made a total look-through investment of £175 million which included:

?

New platform deals - £50 million - Thomas' London Day Schools, Liberty Dental Group and Webcentral

?

Reinvestment - £66 million - IU Group, benefitting from the next phase of the company's growth which is focused on leveraging AI and internationalisation

?

Follow-on investments - £35 million - in addition to vLex's acquisition of Fastcase, and the acquisition of 7Mind by 7NXT which owns and operates fitness platform Gymondo, 22 bolt-on acquisitions were completed by portfolio companies

?

Venture investments - £24 million - investments in Oakley Touring Venture Fund and PROfounders III portfolio companies

 

Read more about OCI's new investments in the Annual Report here.

 

Post balance-sheet events

?

Further new platform deals - c.£80 million - investments in Alerce and Steer Automotive Group. These transactions are expected to complete within H1 2024.

 

Direct investments

 

The Board continues to work towards the resolution and value maximisation of OCI's two direct investments of Time Out and North Sails. Developments in 2023 included: the receipt of an in-specie dividend of Time Out shares from the ongoing closure of Fund I which rationalised OCI's Time Out holdings in a single direct stake, giving greater autonomy over the holding; and converting OCI's outstanding North Sails loans and accrued interest into preferred equity. This was done alongside a wider organisational and capital restructure of the North Sails Group which improves OCI's overall security, creates an incentive for redemption and helps simplify the North Sails' capital structure, enhancing the attraction of the business to future investors. Time Out recently publicly reported strong half year results while North Sails delivered another record year for 2023.

 

Read more about OCI's direct investments in the Annual Report here.

 

Cash & commitments

 

OCI made a total commitment of $100 million in Oakley Touring Venture Fund and ?190 million in Origin II, taking the total outstanding commitments to the Oakley Funds to £1,015 million as at 31 December 2023. This will be deployed into new investments over the next five years. OCI's total liquidity as at 31 December 2023 was £382 million, comprising £207 million of cash on the balance sheet and £175 million in undrawn credit facilities. The Board closely monitors anticipated fund drawdowns and projected liquidity and will continue its long-term commitment to share buybacks when appropriate.

 

See OCI's Balance Sheet in the Annual Report here.

 

Outlook

The underlying portfolio is expected to continue generating strong earnings growth in spite of the prevailing macroeconomic uncertainty, while investment activity is anticipated to remain robust after a busy period:

?

Portfolio companies continue to benefit from long-term trends including the consumer shift to digital search and spend, businesses' shift to the cloud and to outsourcing, and resilient demand for education and up-skilling

?

There remains a strong environment for new investment opportunities with five new deals signed in the last four months, laying the foundations for future earnings and NAV growth

?

OCI's enhanced balance sheet and liquidity means it can fully participate in the Investment Adviser's strong pipeline with opportunities in due diligence weighted towards Southern and Western Europe, and Technology, Education and Business Services sectors

 

 

Caroline Foulger, Chair of Oakley Capital Investments, commented:

 

"It is testament to the resilience of the underlying portfolio and Oakley's active management that, in spite of the unsettled nature of the global economy, the Company continued to deliver. Most importantly, total shareholder return was 18%, taking the annualised five-year total shareholder return to 24%. OCI continues to offer one of the most accessible ways to gain exposure to pan-European private equity through one of the industry's best performing managers."

Peter Dubens, Managing Partner of Oakley Capital, commented:

 

"We are in a period of sustained uncertainty, triggered by macroeconomic volatility but also technological disruption not least with the advent of generative AI. While this can create challenges for our portfolio companies and the entrepreneurs we partner with, it can also create opportunities. Many of our existing investments are already leveraging AI to boost productivity and, in some cases, to completely pivot their business models.

 

"Meanwhile, our approach to partnership and strong track record in value creation continue to make Oakley the partner of choice for ambitions founders and management teams who are building disruptive leaders in often highly fragmented markets."

 

The Annual Report and Accounts are available on the Company's website at  https://www.oakleycapitalinvestments.com/2023-annual-report/

 

A video overview of the 12-month performance is also available here https://www.oakleycapitalinvestments.com/news-and-media/videos/

 

The Company's Q1 2024 trading update is expected to be released on 24 April 2024.

 

- ends -

 

Results presentation

 

A live presentation of the results, delivered by Oakley Capital Partner Steven Tredget, will take place at 9:00am today, Thursday 14 March 2024. The presentation will be available to view via video webcast at the following link: https://www.investis-live.com/oakley-capital/65d47bebd0d520120031aad6/ozre

Dividend

The final dividend declared in respect of the year ended 31 December 2023 is 2.25 pence per share (following the interim dividend of 2.25 pence, bringing the full-year dividend to 4.5 pence per share.)

 

Ex-dividend date

14 March 2024

(date from which shares are transferred without dividend)

 

Record date

22 March 2024

(last date for registering transfers to receive the dividend)

 

Dividend payment date

26 April 2024

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

 

Greenbrook Communications Limited

+44 20 7952 2000

Rob White / Michael Russell

 

Deutsche Numis (Financial Adviser & Broker)

+44 20 7260 1000

Nathan Brown / Matt Goss

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

1 About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/. The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

2 Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

3 The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V, Oakley Capital Origin Fund and Oakley Capital Origin II, are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

For more information on the Oakley Fund strategies in which OCI invests, please click here.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

This announcement may include "forward-looking statements". These forward-looking statements are statements regarding the Company's objectives, intentions, beliefs or current expectations with respect to, amongst other things, the Company's financial position, business strategy, results of operations, liquidity, prospects and growth. Forward-looking statements are subject to risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Accordingly the Company's actual future financial results, operational performance and achievements may differ materially from those expressed in, or implied by, the statements. Given these uncertainties, prospective investors are cautioned not to place any undue reliance on such forward-looking statements, which speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the Company's expectations with regard to them or any change in events, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Regulation Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR EAFDDFSDLEAA
Date   Source Headline
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.